These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [The problem of amyloidosis in rheumatic diseases]. Dilşen N; Ulagay I Turk Tip Cemiy Mecm; 1968; 34(11):671-81. PubMed ID: 5306477 [No Abstract] [Full Text] [Related]
27. [Diagnostics and therapy of amyloidosis]. Pettersson T; Törnroth T; Maury P Duodecim; 1999; 115(11):1201-11. PubMed ID: 11877839 [No Abstract] [Full Text] [Related]
32. [Evaluation of the modified bennhold test in the diagnosis of amyloidosis associated with rheumatoid arthritis (author's transl)]. Handlova D; Kutova M Schweiz Rundsch Med Prax; 1974 Jul; 63(28):875-7. PubMed ID: 4409511 [No Abstract] [Full Text] [Related]
33. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068 [TBL] [Abstract][Full Text] [Related]
34. Understanding the basics of primary systemic amyloidosis. Schumacher DL J Contin Educ Nurs; 2004; 35(1):15-6. PubMed ID: 14870905 [No Abstract] [Full Text] [Related]
35. Diagnostic and therapeutic approach of systemic amyloidosis. Hazenberg BP; van Gameren II; Bijzet J; Jager PL; van Rijswijk MH Neth J Med; 2004 Apr; 62(4):121-8. PubMed ID: 15255082 [TBL] [Abstract][Full Text] [Related]
36. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Kyle RA; Gertz MA Semin Hematol; 1995 Jan; 32(1):45-59. PubMed ID: 7878478 [No Abstract] [Full Text] [Related]
37. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline]. Higuchi N; Maruyama H Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036 [TBL] [Abstract][Full Text] [Related]
38. Clinical and biochemical outcome of renal amyloidosis. Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441 [TBL] [Abstract][Full Text] [Related]
39. [Contribution of myocardial biopsy and immunohistochemistry to the prognostic evaluation of cardiac amyloidosis]. Van de Walle JP; Fourcade L; Panagides D; Harle JR; Pellissier JF; Touze JE; Bory M Arch Mal Coeur Vaiss; 1994 Feb; 87(2):235-9. PubMed ID: 7802531 [TBL] [Abstract][Full Text] [Related]
40. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Silverstein SR Dermatol Online J; 2005 Mar; 11(1):5. PubMed ID: 15748546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]